<SEC-DOCUMENT>0001144204-15-030345.txt : 20150514
<SEC-HEADER>0001144204-15-030345.hdr.sgml : 20150514
<ACCEPTANCE-DATETIME>20150513215704
ACCESSION NUMBER:		0001144204-15-030345
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20150514
DATE AS OF CHANGE:		20150513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Recon Technology, Ltd
		CENTRAL INDEX KEY:			0001442620
		STANDARD INDUSTRIAL CLASSIFICATION:	OIL, GAS FIELD SERVICES, NBC [1389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-190387
		FILM NUMBER:		15860102

	BUSINESS ADDRESS:	
		STREET 1:		ROOM 1902, BUILDING C,
		STREET 2:		KING LONG INTL MANSION, NO. 9 FULIN ROAD
		CITY:			BEIJING
		STATE:			F4
		ZIP:			100107
		BUSINESS PHONE:		025-52313015

	MAIL ADDRESS:	
		STREET 1:		ROOM 1902, BUILDING C,
		STREET 2:		KING LONG INTL MANSION, NO. 9 FULIN ROAD
		CITY:			BEIJING
		STATE:			F4
		ZIP:			100107
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>v410706_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;<FONT STYLE="color: #DE1A1E"><B> </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(5)<BR>
Registration No. 333-190387</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Amendment No. 1 to Prospectus Supplement dated May 13, 2015<BR>
(To prospectus dated August 6, 2013)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 50px; width: 240px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $10,000,000</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ordinary Shares</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 3in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;This amendment No. 1 to prospectus
supplement (the &ldquo;Amendment No.1&rdquo;) is being filed solely to correct a typographical error which appear in the prospectus
supplement dated May 13, 2015 (&ldquo;Prospectus Supplement&rdquo;) and to consistently present the increase in net tangible book
value per share to investors participating in this offering in the dilution table and the paragraph immediately above it. This
Amendment No. 1 should be read in conjunction with the Prospectus Supplement and the prospectus dated August 6, 2013 the (&ldquo;Prospectus&rdquo;),
each of which are to be delivered with this Amendment No. 1. This Amendment No. 1 amends only those sections of the Prospectus
Supplement set forth in this amendment; all other sections of the Prospectus Supplement remain unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If you invest in our ordinary shares, your
interest will be diluted immediately to the extent of the difference between the public offering price per share and the adjusted
net tangible book value per share of our ordinary shares after this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Our net tangible book value on December
31, 2014 was approximately $16&nbsp;million, or $3.39 per share. &ldquo;Net tangible book value&rdquo; is total assets minus the
sum of liabilities and intangible assets. &ldquo;Net tangible book value per share&rdquo; is net tangible book value divided by
the total number of shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">After giving effect to the sale of our
ordinary shares in the aggregate amount of $2,203,306 in this offering at an assumed offering price of $1.88 per share, which was
the last reported sale price of our ordinary shares on the NASDAQ Capital Market on May 11, 2015, and after deducting estimated
offering commissions and expenses payable by us, our net tangible book value as of December 31, 2014 would have been approximately
$18.0 million, or $3.05 per ordinary shares. This represents an immediate decrease in net tangible book value of $0.34 per share
to our existing stockholders and an immediate increase in net tangible book value of $1.17 per share to investors participating
in this offering. The following table illustrates this dilution per share to investors participating in this offering:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Assumed offering price per share&#9;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">1.88</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Net tangible book value per share as of December 31, 2014&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">3.39</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Dilution per share attributable to new investors&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.34</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 0.1in">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Net tangible book value per share after giving effect to this offering&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">3.05</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 0.1in">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Increase per share to new investors&#9;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The table above assumes, for illustrative
purposes that an aggregate of 1,171,971 of our ordinary shares are sold at a price of $1.88 per share, the last reported sale price
of our ordinary shares on the NASDAQ Capital Market on May 11, 2015, for aggregate gross proceeds approximately of $2.2 million.
The shares sold in this offering, if any, will be sold from time to time at various prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The above discussion and table are based
on <FONT STYLE="background-color: white">4,726,711</FONT> shares outstanding as of December 31, 2014 and exclude:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The number of our ordinary shares that
will be outstanding immediately after this offering as shown above is based on 5,022,436 shares outstanding as of May 11, 2014.
The number of shares outstanding as of the date of this prospectus supplement, as used throughout this prospectus supplement, unless
otherwise indicated, excludes the following, all as of December 31, 2014:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 33px">&nbsp;</td>
    <td style="width: 33px"><font style="font-size: 10pt">&bull;</font></td>
    <td><font style="font-size: 10pt">193,000 ordinary shares issuable upon the exercise of outstanding stock options under our 2009 Equity Incentive Plan with an initial exercise price of $6.00 per share;</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 33px">&nbsp;</td>
    <td style="width: 33px"><font style="font-size: 10pt">&bull;</font></td>
    <td><font style="font-size: 10pt">222,600 ordinary shares issuable upon the exercise of outstanding stock options under our 2009 Equity Incentive Plan with an initial exercise price of $2.96 per share; and</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 33px">&nbsp;</td>
    <td style="width: 33px"><font style="font-size: 10pt">&bull;</font></td>
    <td><font style="font-size: 10pt">an aggregate of 700,000 ordinary shares reserved for future issuance under our 2015 Equity Incentive Plan.</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">To the extent that any of our outstanding
options or warrants are exercised, we grant additional options or other awards under our stock incentive plan or issue additional
warrants, or we issue additional ordinary shares in the future, there may be further dilution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;Except as set
forth above, the Prospectus Supplement and the Prospectus remain unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">_____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this amendment No. 1 to prospectus
supplement is May 13, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX.
M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_
MVP!#`0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P``1"``R`/`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:J]_=QV%
MA/=2D!(8RY)]A4]<!\8M;_LWPB;.-L2WS^7P?X1R:NG#GDHB9X=J>J3ZGJEU
M>R2-NGE9^O8GBJWG2_\`/1_SJ.NZ^%W@VU\5ZC=OJ4;/9VZ`84XRY]Z]N<E3
MC=]#):LXGSI?^>C_`)T">8'(E<$>]?0+_!_PJRD"UF7/<2FO%?&&BV_A[Q1>
M:;:3&6&$C:6ZC(Z&LZ6(A5=D-QL.TGQKK^B2*UEJ4VQ3DQ.=RM^%?0O@_P`1
M)XI\.6VI*@1W&V1!_"PZU\NDX&:^BOA1ITFG>`[3S@5:=FFP?0GBL,;"*CS=
M1P;.SI::S*BEF("CJ2>!7+:O\2O#6C2-'-J"RRKU2$;R/RXKSHQE+9&AU=%>
M;M\;_#X8@6]X1Z[!6GI?Q9\,:E*L1NGMG8X'GIM'YU;H5%JXBNCM:*8DB2QJ
M\;!D89#*<@BG5D,6BHKBYAM86EN)4BC7J[M@#\:X_4?BSX7T^1HQ=M<,O7R4
M)'YU482E\*"YVE+7FW_"[]`W?\>]YCUV"MK1OB?X:UF98([WR)FX59UVY/UZ
M5;H5$KM"NCKZ*0$$`@Y!HK(8M%5;[4;33+<SWUS%;Q#JTC`5QU_\8?#%FY2.
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M8X4$X'XU=\1>%-5\+7$<6JP!!)]QU.5;\:[ZBA/W)$*ZU.XU3XXW]Q`\>FZ=
M';LPP))&W%?PKS*XGENKB2XN)&DED8L[L>234=>B_##0_"VOWGV?4HYY-1C&
M\12-^[<#T_PJ'&%"+DD/61D^`?`EUXLU*.6:-H]+B8&64C&__96OH&\O++0=
M)>XN'6"TMD_``=`*LV]O#:0)#;Q)%$@PJ(,`5XK\9_$[WFK1Z%;N1;VP#S`'
M[SGH/PKAYI8JHET+^%&'XT^).H^*+AX+:1[330<+$APT@]6/]*Y[0_#VH^(K
MW[+I5LTT@Y9NBJ/4FLVO2/"'Q-TOPEH<=C!HTSR_>FF#@>8WK7?).E"U-$;O
M4R=<^%NOZ#I;W\X@FAB&9!$V2H]:XW@CU!KUC6OC1;ZIHMY8QZ3-&]Q$T89I
M`0,C&:\G`P`**+J-/VB$[=#V3X)>(KBYBO-&N9&D2!1)"6.2H/!'TKO_`!3X
MHLO"FD/>WK9/2*(?>D;T%>8_`NR9M2U2^(Q&D:Q@^_4URWQ(\3/XC\5S[')M
M+0F*%>W'4_G7)*@JE=I;%WM$H^)_&6J^*[MI+Z=EMP?DMT.$4?U-9VF:/?ZQ
M.8=,LY;EQU$:\#ZFET;2I]<UBUTZV'[RX<+G^Z.YKZ<\/Z!9>'-+BL;")41!
M\S8Y<]R36]:M&@E&*)2YCYJU?PQK&@JCZI836\;G"NPR,^F:RCCO7U7X@T&T
M\2:3)I]\&,,A!.TX(QZ5SUK\)O"MMC-BTI'_`#TD)K.&.C;WEJ-P*?P>\03Z
MSX6>WNI#)+92>6&)R2O:M+QWX\M?!UB%`$VH3#]S#GI_M-[5J1V.D>#M(N[F
MSM8K6"-#))L'WL"OFO7=9N?$&LW&HW3%GF8E0>BKV`K&E2C7J.5M"F[(=K?B
M#4O$5XUSJET\S'HN?E3V`J32O"VM:W$9--TV>>(?QA<*?QK1^'WA<>*_$T5M
M,#]DA'FSX[CL/QKZ1M[:&TMT@MXUBB085$&`!717Q"H^Y%$J-]6?)UW9W&GW
M3VUY"\$\9PT;C!%/TS4[G1M0AOK&1HIX6#`J<9]C[5W'QIFAD\:1I$%\R.W`
MD(]>V:\].2,`9)X%=,)>T@FUN2]&?5^B:BNKZ+9WRC'GQ*Y'H<<UXC\9-;_M
M+Q8MC&V8K%-I'^V>37K>AX\.^`;5[GY1:V@=\_3-?-FH7TFI:C<WLQ)DGD9R
M3[FN#"4U[1RZ(N3T*XQD9&0#TK3U35=4U\)+<B:2W@0)&B*?+B4=AVK1\!>&
M/^$K\316DN?LL0\R<C^Z.WXU]#2VNG:/HDRI;0Q6D,3$H%&,`5T5\1&G)*UV
M2HW1\J#VJ>QDEBO[>2W)699`4*]0:9<.LMU-)&NV-Y&90.PSQ72_#?1CK?C:
MRC9=T-N?.D],"NB<DHN3$EJ>F?&K6_L7AJ+38VQ+>R?,!_<'6O"Z['XK:X-8
M\:SI&X:"S40H0>">_P"M<86&.HK+#0Y*:'+5GJ7P0T3[1J]YJ\B_);KY49/]
MX]?TKJ_C/IXN_!8N0,O:S*P^AX-:_P`-M$_L/P791,N)IE\Z3ZM_]:M#QC8#
M4_".IVV,EH&(^HYKSYU;U^;S+2T/EVM7PKJ#Z7XJTV[1BI6=02/0G!K(#`#!
M(R*59/+=74\HP8?A7K25XM&:/KS<-FX<C&17RKXCN7O/$FI3R$EWN'SGZU].
M:'=B_P!"L;D'(E@5L_A7@?Q+\*7/A_Q)<7(B8V%VYDCD`X!/537FX)J,VGN7
M/8P_"^EP:UXFL-/NY#'!<2;68'!KV+_A2/A[_GM>?]]UX3'(T<BR1N5=3N5E
M."#71S?$7Q/-9_9GU>41XVDC`8CZUUUJ=233A*Q*:6YW\WPW\"V]VUK-K+).
MGWD:X`(JQ%\)_!T^/*U.1\]-MPIKQJVM+K5+H1VT,UU<2'HH+$GW->Q?#_X4
MMILL6IZ^=UPI#16P;A#ZMZGVK"JG35W-E+7H=.F@V?@3P1J::7O.(GD+.<L3
MC%?.&XMEF.2QR37UI?V<>H:?/:3#]W-&4;\17S!XD\-WOA?59;*]B955CY<N
M/E=>Q!HP4TW*^[":.C^$$MI#XZC-TZHS0LL1;@;J^@99HX(FDFD6-%&2S'`%
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M[^95V@[(\_,Y[`"OER"YEM91+;3/%(.CHV#2W%Y<7LH>ZN)9Y.Q=BQJJF$4Z
MG,WH"E9%G6=5GUO6+K4;G_67#EL?W1V%=#\-O"<GB;Q)%)(A^PVC"29L<$CH
MM+X3^&VK^)IDDDB>SL<_--(,$C_9'>O>]!T&R\.:7%8:=$$B3J>[GN2?6EB,
M1&$>2&X1C?5G'?&76AIOA-+")MLEZX3`_N#DUX+TKM_BWKHU;QG)!&X,-DGE
M+@\;NIKC+6W>^NX;6'YI)G"*!ZDUKAH<E)7%+5GMWP3T3['X=GU.1<27CX7/
M]P?_`%ZO_%_6_P"R_!SVL;8FOF$0_P!WJ:Z[1=-32-%M+&(86")4_''->&_&
M+71J7BX6<;YAL4V<'C>>37%2_?5^9EO1'!],"O:?@?HGD:5>:O(OSW+^7&2/
MX1U_6O%XHVN)HX8N7D8(H'J3BOJCPUI2:)X>L;!`!Y,0#8]>]=.-G:'+W)@C
MA9-)T]Y69K&U+$Y),*\_I2+H^G;T_P")?:?>'_+%?7Z444+8#TR,!8D````&
M`*)0&B<$`@J<@T45Y?4T/,CI&G;F_P!`M/O'_EBO^%!T?3L'_B7VG_?E?\**
M*]1;&9Z#HL:1:/:I&BHBI@*HP!4U];PW-G+'<11RH5Y5U##\C117F_;^9?0^
M??%MG;0:G*L-O%&`QX5`*J:#;02WB"2&-AGHR`T45[*^$SZGOOARPM+73HVM
M[6"%B.3'&%/Z5L445Y%;XV:(*S=>M+>[TJ87-O%,`O`D0-C\Z**FE\:!['SS
MX@MH8KYUCAC09Z*H%6_"=I;SZE&LT$4@W=&0&BBO:^R9=3Z"TRTM[2QC6V@B
MA4J.(T"C]*MT45XL_B9L@KGO&EC:W.B2/<6T,K*.&>,,1^=%%51^-">Q\^W<
M,2WS!8T`ST"BO5/AMIEC(`\EE;,X'#-$I/\`*BBO4K_`9K<]/``````'8444
M5XS-3SV\TG3Y+R=WL+5G:0DL85)/Z5-I&DZ?'J]L\=C:JROD,L*@C]***]'[
M!F=Y7G^HZ582ZE<O)8VKNTA)9H5)//KBBBN?#;LN0NG:1IR:G;,EA:JPD!!$
..*@@_E7?BBBC$[H43_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
